Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05202314 | Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer(NACSOC-02) | recruiting | N/A | 20 | Beijing Chao Yang HospitalOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05602974 | Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study | not yet recruiting | N/A | 140 | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| 1 |
| Feb 17, 2023 |
| clinicaltrials |
| NCT04999696 | Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical Cancer(MITOR) | not yet recruiting | N/A | 820 | Chang Gung Memorial HospitalOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT03836196 | Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease(OPTiMAL) | recruiting | N/A | 105 | British Columbia Cancer AgencyOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT01958762 | Screening for Cancers in the Oral CAvity(IDECAB) | recruiting | N/A | 100 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05717790 | Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma | recruiting | N/A | 288 | Fourth Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05718492 | A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents | recruiting | N/A | 100 | Sun Yat-sen UniversityOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05698264 | A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC | not yet recruiting | N/A | 50 | Nir PeledOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05698576 | TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer(TPF-LITT) | recruiting | N/A | 20 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT02400658 | Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer | active not recruiting | N/A | 358 | Shayna Showalter, MDOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05681403 | Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma | not yet recruiting | N/A | 53 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05681416 | Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer(ProFam-Risk) | not yet recruiting | N/A | 300 | Heinrich-Heine University, DuesseldorfOTHER | 0 | Jan 12, 2023 | clinicaltrials |
| NCT05676190 | Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer | recruiting | N/A | 80 | ShiCang YuOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT02261389 | Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET | active not recruiting | N/A | 1,507 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT05665920 | Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy(HYPHEN) | recruiting | N/A | 36 | Instituto Brasileiro de Controle do CancerOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT04472845 | HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).(HYPART) | recruiting | N/A | 1,018 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05636384 | SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)(HOMECARE) | recruiting | N/A | 396 | Seoul National University HospitalOTHER | 1 | Dec 5, 2022 | clinicaltrials |
| NCT04720339 | Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy. | recruiting | N/A | 250 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT05620693 | Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma | recruiting | N/A | 20 | Shenzhen University General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT05620706 | Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma | recruiting | N/A | 20 | Shenzhen University General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT05620732 | Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T | recruiting | N/A | 20 | Shenzhen University General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT00860652 | Radiotherapy - Adjuvant Versus Early Salvage(RAVES) | active not recruiting | N/A | 333 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Nov 18, 2022 | clinicaltrials |
| NCT05621902 | Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer(LUCA-S) | not yet recruiting | N/A | 398 | Mats LambeOTHER | 0 | Nov 18, 2022 | clinicaltrials |
| NCT05622474 | A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy | not yet recruiting | N/A | 236 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2022 | clinicaltrials |
| NCT05620680 | CD7 CAR-T Cells in T-cell Lymphoma/Leukemia | recruiting | N/A | 20 | Shenzhen University General HospitalOTHER | 1 | Nov 17, 2022 | clinicaltrials |
| NCT04451473 | Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery | recruiting | N/A | 350 | The Second Hospital of Shandong UniversityOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT04688801 | Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer | recruiting | N/A | 200 | The Second Hospital of Shandong UniversityOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT05613504 | Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer. | not yet recruiting | N/A | 90 | Nanjing University of Traditional Chinese MedicineOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT05614700 | Prostate Reirradiation Toxicity Outcomes Feasibility Study(RO-PIP) | not yet recruiting | N/A | 60 | University of LeedsOTHER | 0 | Nov 15, 2022 | clinicaltrials |
| NCT02044172 | Prostate Testing for Cancer and Treatment(ProtecT) | active not recruiting | N/A | 82,849 | University of OxfordOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT04512937 | Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer(NAVI-LARRC) | active not recruiting | N/A | 20 | Oslo University HospitalOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT04871399 | Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer(CoME-In) | recruiting | N/A | 416 | University of Turin, ItalyOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05611359 | Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer(HOPE-1) | not yet recruiting | N/A | 60 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Nov 10, 2022 | clinicaltrials |
| NCT04078230 | Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma | recruiting | N/A | 168 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 2 | Nov 9, 2022 | clinicaltrials |
| NCT05502224 | Multidisciplinary Approach to Fatigue | recruiting | N/A | 50 | Jules Bordet InstituteOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT05607329 | Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial | recruiting | N/A | 400 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05597852 | Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer(FIRST STAR) | recruiting | N/A | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05585554 | Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy(LAP-ABLATE) | not yet recruiting | N/A | 267 | Viewray Inc.INDUSTRY | 0 | Oct 19, 2022 | clinicaltrials |
| NCT03621644 | Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer | active not recruiting | N/A | 133 | Viewray Inc.INDUSTRY | 2 | Oct 14, 2022 | clinicaltrials |
| NCT04527861 | Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer(CSILS) | recruiting | N/A | 710 | Ruijin HospitalOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT05562375 | Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders | recruiting | N/A | 73 | Universidad Rey Juan CarlosOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT03747588 | The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer(MIOPP) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05537129 | Laparoscopic vs Open Total Gastrectomy for Gastric Cancer | recruiting | N/A | 600 | Fudan UniversityOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT05510830 | Diagnostic Cervical Conization for Persistent Infection or Integration of HPV | not yet recruiting | N/A | 250 | Tongji HospitalOTHER | 1 | Sep 8, 2022 | clinicaltrials |
| NCT05529615 | Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer(CTAC) | recruiting | N/A | 2,684 | Peking University Cancer Hospital & InstituteOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT05528237 | HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals(ACCESS) | enrolling by invitation | N/A | 50 | University of WashingtonOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT05494021 | China Lung Cancer Screening (CLUS) Study Version 3.0 | recruiting | N/A | 100,000 | Shanghai Chest HospitalOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05491395 | Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction(PROMART) | recruiting | N/A | 120 | Barretos Cancer HospitalOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT05460819 | Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer. | not yet recruiting | N/A | 90 | Nanjing University of Traditional Chinese MedicineOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT05285332 | Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy(CS) | not yet recruiting | N/A | 362 | Changhai HospitalOTHER | 0 | Jul 19, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Feb 21, 2023source: clinicaltrials